Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 2R1 (CYP2R1) is a microsomal enzyme in the cytochrome P450 superfamily responsible for the 25-hydroxylation of vitamin D in the liver, the essential first activation step in vitamin D metabolism. It converts both dietary and cutaneously synthesized vitamin D (vitamin D₃ and vitamin D₂) to 25-hydroxyvitamin D, the principal circulating form, which is used to assess vitamin D status clinically. Mutations in the CYP2R1 gene cause rare forms of vitamin D-deficiency rickets. CYP2R1 is highly selective for vitamin D as a substrate, localizes on chromosome 11p15.2, and has a typical P450 structure with specific substrate channel dynamics. CYP2R1 activity is essential for proper bone health, calcium/phosphate homeostasis, and prevention of bone softening diseases. No specific drugs target CYP2R1 for therapeutic purposes, but its function is critical for the efficacy of vitamin D supplementation and in rare cases of genetic deficiency may require specific medical intervention.
Substrate hydroxylation: CYP2R1 catalyzes the conversion of vitamin D (D₃ or D₂) to 25-hydroxyvitamin D, enabling vitamin D activation cascade.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 2R1 (CYP2R1).